BG106040A - Интегрин - рецепторни антагонисти - Google Patents

Info

Publication number

BG106040A

BG106040A BG106040A BG10604001A BG106040A BG 106040 A BG106040 A BG 106040A BG 106040 A BG106040 A BG 106040A BG 10604001 A BG10604001 A BG 10604001A BG 106040 A BG106040 A BG 106040A

Authority

BG

Bulgaria

Prior art keywords

gly

bala

bhs

phhs

tolhs

Prior art date

1999-04-28

Links

• Espacenet
• Global Dossier
• Discuss

• 229940127449 Integrin Receptor Antagonists Drugs 0.000 title abstract description 7
• 150000001875 compounds Chemical class 0.000 claims abstract description 143
• 108010044426 integrins Proteins 0.000 claims abstract description 33
• 102000006495 integrins Human genes 0.000 claims abstract description 33
• 238000011282 treatment Methods 0.000 claims abstract description 31
• 239000000825 pharmaceutical preparation Substances 0.000 claims abstract description 18
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
• 201000010099 disease Diseases 0.000 claims abstract description 10
• -1 alkylaryl radical Chemical class 0.000 claims description 372
• 150000003254 radicals Chemical class 0.000 claims description 99
• 125000003118 aryl group Chemical group 0.000 claims description 62
• 229920006395 saturated elastomer Polymers 0.000 claims description 55
• 239000005557 antagonist Substances 0.000 claims description 52
• 229910052757 nitrogen Inorganic materials 0.000 claims description 41
• 125000005842 heteroatom Chemical group 0.000 claims description 39
• 125000000623 heterocyclic group Chemical group 0.000 claims description 39
• 229910052717 sulfur Inorganic materials 0.000 claims description 37
• 229910052739 hydrogen Inorganic materials 0.000 claims description 36
• 239000001257 hydrogen Substances 0.000 claims description 34
• 239000003112 inhibitor Substances 0.000 claims description 28
• 238000002360 preparation method Methods 0.000 claims description 22
• 239000003814 drug Substances 0.000 claims description 20
• 150000002431 hydrogen Chemical class 0.000 claims description 20
• 230000015572 biosynthetic process Effects 0.000 claims description 19
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 17
• 229940124531 pharmaceutical excipient Drugs 0.000 claims description 16
• 206010028980 Neoplasm Diseases 0.000 claims description 15
• 125000002877 alkyl aryl group Chemical group 0.000 claims description 15
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
• 210000004027 cell Anatomy 0.000 claims description 14
• 229910052736 halogen Inorganic materials 0.000 claims description 13
• 150000002367 halogens Chemical class 0.000 claims description 13
• 150000003839 salts Chemical class 0.000 claims description 13
• 125000003107 substituted aryl group Chemical group 0.000 claims description 13
• 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 11
• 125000000896 monocarboxylic acid group Chemical group 0.000 claims description 11
• 239000008194 pharmaceutical composition Substances 0.000 claims description 11
• 125000001424 substituent group Chemical group 0.000 claims description 11
• 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 10
• 230000001404 mediated effect Effects 0.000 claims description 10
• 208000001132 Osteoporosis Diseases 0.000 claims description 8
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
• 239000002412 selectin antagonist Substances 0.000 claims description 8
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 7
• 208000006011 Stroke Diseases 0.000 claims description 7
• MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims description 7
• 239000003963 antioxidant agent Substances 0.000 claims description 7
• 201000011510 cancer Diseases 0.000 claims description 7
• 229920000669 heparin Polymers 0.000 claims description 7
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
• 229940127215 low-molecular weight heparin Drugs 0.000 claims description 7
• 208000037803 restenosis Diseases 0.000 claims description 7
• 238000006467 substitution reaction Methods 0.000 claims description 7
• 239000005541 ACE inhibitor Substances 0.000 claims description 6
• 201000001320 Atherosclerosis Diseases 0.000 claims description 6
• 125000003601 C2-C6 alkynyl group Chemical class 0.000 claims description 6
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 6
• 108090000190 Thrombin Proteins 0.000 claims description 6
• 230000002776 aggregation Effects 0.000 claims description 6
• 238000004220 aggregation Methods 0.000 claims description 6
• 229940127282 angiotensin receptor antagonist Drugs 0.000 claims description 6
• 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 claims description 6
• 230000000694 effects Effects 0.000 claims description 6
• 229960002897 heparin Drugs 0.000 claims description 6
• 102000005962 receptors Human genes 0.000 claims description 6
• 108020003175 receptors Proteins 0.000 claims description 6
• 229960004072 thrombin Drugs 0.000 claims description 6
• 230000029663 wound healing Effects 0.000 claims description 6
• 102000055006 Calcitonin Human genes 0.000 claims description 5
• 108060001064 Calcitonin Proteins 0.000 claims description 5
• 229940127291 Calcium channel antagonist Drugs 0.000 claims description 5
• 102000002045 Endothelin Human genes 0.000 claims description 5
• 108050009340 Endothelin Proteins 0.000 claims description 5
• 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
• 201000002980 Hyperparathyroidism Diseases 0.000 claims description 5
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims description 5
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims description 5
• 206010053648 Vascular occlusion Diseases 0.000 claims description 5
• 230000004913 activation Effects 0.000 claims description 5
• 230000033115 angiogenesis Effects 0.000 claims description 5
• BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims description 5
• 229960004015 calcitonin Drugs 0.000 claims description 5
• 239000000480 calcium channel blocker Substances 0.000 claims description 5
• 201000009101 diabetic angiopathy Diseases 0.000 claims description 5
• ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 claims description 5
• 208000010125 myocardial infarction Diseases 0.000 claims description 5
• 239000002243 precursor Substances 0.000 claims description 5
• 239000000021 stimulant Substances 0.000 claims description 5
• 239000005483 tyrosine kinase inhibitor Substances 0.000 claims description 5
• 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims description 5
• 208000021331 vascular occlusion disease Diseases 0.000 claims description 5
• 206010007559 Cardiac failure congestive Diseases 0.000 claims description 4
• 229940118365 Endothelin receptor antagonist Drugs 0.000 claims description 4
• 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims description 4
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 4
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 4
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 4
• 208000024248 Vascular System injury Diseases 0.000 claims description 4
• 208000012339 Vascular injury Diseases 0.000 claims description 4
• 150000001413 amino acids Chemical class 0.000 claims description 4
• 150000001602 bicycloalkyls Chemical group 0.000 claims description 4
• 235000012000 cholesterol Nutrition 0.000 claims description 4
• 229940079593 drug Drugs 0.000 claims description 4
• 239000002308 endothelin receptor antagonist Substances 0.000 claims description 4
• 230000035755 proliferation Effects 0.000 claims description 4
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 4
• 238000002560 therapeutic procedure Methods 0.000 claims description 4
• 206010003178 Arterial thrombosis Diseases 0.000 claims description 3
• 102100032912 CD44 antigen Human genes 0.000 claims description 3
• 229940123583 Factor Xa inhibitor Drugs 0.000 claims description 3
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 3
• 206010020772 Hypertension Diseases 0.000 claims description 3
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims description 3
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 claims description 3
• 102000004890 Interleukin-8 Human genes 0.000 claims description 3
• 108090001007 Interleukin-8 Proteins 0.000 claims description 3
• 208000003076 Osteolysis Diseases 0.000 claims description 3
• 201000004681 Psoriasis Diseases 0.000 claims description 3
• 229940122388 Thrombin inhibitor Drugs 0.000 claims description 3
• 208000007536 Thrombosis Diseases 0.000 claims description 3
• 230000001154 acute effect Effects 0.000 claims description 3
• 238000002399 angioplasty Methods 0.000 claims description 3
• 238000011444 antiresorptive therapy Methods 0.000 claims description 3
• 238000002657 hormone replacement therapy Methods 0.000 claims description 3
• 208000017169 kidney disease Diseases 0.000 claims description 3
• 208000029791 lytic metastatic bone lesion Diseases 0.000 claims description 3
• 206010062198 microangiopathy Diseases 0.000 claims description 3
• 229940044551 receptor antagonist Drugs 0.000 claims description 3
• 239000002464 receptor antagonist Substances 0.000 claims description 3
• 239000003868 thrombin inhibitor Substances 0.000 claims description 3
• 229940122361 Bisphosphonate Drugs 0.000 claims description 2
• 102000029816 Collagenase Human genes 0.000 claims description 2
• 108060005980 Collagenase Proteins 0.000 claims description 2
• 101100289989 Drosophila melanogaster alpha-Man-Ia gene Proteins 0.000 claims description 2
• 229940123457 Free radical scavenger Drugs 0.000 claims description 2
• 229940121672 Glycosylation inhibitor Drugs 0.000 claims description 2
• 102000002265 Human Growth Hormone Human genes 0.000 claims description 2
• 108010000521 Human Growth Hormone Proteins 0.000 claims description 2
• 239000000854 Human Growth Hormone Substances 0.000 claims description 2
• 108010008212 Integrin alpha4beta1 Proteins 0.000 claims description 2
• 102000000589 Interleukin-1 Human genes 0.000 claims description 2
• 108010002352 Interleukin-1 Proteins 0.000 claims description 2
• 102000000743 Interleukin-5 Human genes 0.000 claims description 2
• 108010002616 Interleukin-5 Proteins 0.000 claims description 2
• 229940127448 Interleukin-6 Antagonists Drugs 0.000 claims description 2
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims description 2
• 101150021286 MAS1 gene Proteins 0.000 claims description 2
• 229940123313 MCP-1 antagonist Drugs 0.000 claims description 2
• 230000000118 anti-neoplastic effect Effects 0.000 claims description 2
• 239000002876 beta blocker Substances 0.000 claims description 2
• 229940097320 beta blocking agent Drugs 0.000 claims description 2
• 150000004663 bisphosphonates Chemical class 0.000 claims description 2
• 230000003683 cardiac damage Effects 0.000 claims description 2
• 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 claims description 2
• 230000015271 coagulation Effects 0.000 claims description 2
• 238000005345 coagulation Methods 0.000 claims description 2
• 229960002424 collagenase Drugs 0.000 claims description 2
• 230000000295 complement effect Effects 0.000 claims description 2
• 239000004074 complement inhibitor Substances 0.000 claims description 2
• 239000000824 cytostatic agent Substances 0.000 claims description 2
• 230000001085 cytostatic effect Effects 0.000 claims description 2
• 239000003166 dihydrofolate reductase inhibitor Substances 0.000 claims description 2
• 229960003444 immunosuppressant agent Drugs 0.000 claims description 2
• 239000003018 immunosuppressive agent Substances 0.000 claims description 2
• 238000002513 implantation Methods 0.000 claims description 2
• 230000037361 pathway Effects 0.000 claims description 2
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 2
• 239000002571 phosphodiesterase inhibitor Substances 0.000 claims description 2
• 230000010118 platelet activation Effects 0.000 claims description 2
• 230000002062 proliferating effect Effects 0.000 claims description 2
• 239000002516 radical scavenger Substances 0.000 claims description 2
• 239000003001 serine protease inhibitor Substances 0.000 claims description 2
• 230000019491 signal transduction Effects 0.000 claims description 2
• 102000009076 src-Family Kinases Human genes 0.000 claims description 2
• 108010087686 src-Family Kinases Proteins 0.000 claims description 2
• 230000003612 virological effect Effects 0.000 claims description 2
• 102000008607 Integrin beta3 Human genes 0.000 claims 2
• 108010020950 Integrin beta3 Proteins 0.000 claims 2
• 229940124761 MMP inhibitor Drugs 0.000 claims 2
• 230000036755 cellular response Effects 0.000 claims 2
• 239000003055 low molecular weight heparin Substances 0.000 claims 2
• 208000035143 Bacterial infection Diseases 0.000 claims 1
• 102100025390 Integrin beta-2 Human genes 0.000 claims 1
• 102000015696 Interleukins Human genes 0.000 claims 1
• 108010063738 Interleukins Proteins 0.000 claims 1
• 102000000853 LDL receptors Human genes 0.000 claims 1
• 108010001831 LDL receptors Proteins 0.000 claims 1
• 102000008299 Nitric Oxide Synthase Human genes 0.000 claims 1
• 108010021487 Nitric Oxide Synthase Proteins 0.000 claims 1
• 208000030852 Parasitic disease Diseases 0.000 claims 1
• 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 1
• 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 1
• 239000003146 anticoagulant agent Substances 0.000 claims 1
• 229940127219 anticoagulant drug Drugs 0.000 claims 1
• 210000000988 bone and bone Anatomy 0.000 claims 1
• 230000020764 fibrinolysis Effects 0.000 claims 1
• 230000023404 leukocyte cell-cell adhesion Effects 0.000 claims 1
• 230000003071 parasitic effect Effects 0.000 claims 1
• 238000007911 parenteral administration Methods 0.000 claims 1
• 230000004936 stimulating effect Effects 0.000 claims 1
• 230000002792 vascular Effects 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 abstract 1
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 132
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 113
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 84
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 73
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 54
• QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 43
• 239000000203 mixture Substances 0.000 description 38
• 239000011347 resin Substances 0.000 description 36
• 229920005989 resin Polymers 0.000 description 36
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 34
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
• 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 33
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 33
• 239000000243 solution Substances 0.000 description 30
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 27
• 125000006239 protecting group Chemical group 0.000 description 26
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 24
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
• 238000006243 chemical reaction Methods 0.000 description 24
• 238000000034 method Methods 0.000 description 22
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
• 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 20
• 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 17
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 16
• 229960000583 acetic acid Drugs 0.000 description 16
• KPCZJLGGXRGYIE-UHFFFAOYSA-N [C]1=CC=CN=C1 Chemical group [C]1=CC=CN=C1 KPCZJLGGXRGYIE-UHFFFAOYSA-N 0.000 description 14
• 229940000635 beta-alanine Drugs 0.000 description 14
• 239000002244 precipitate Substances 0.000 description 14
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 13
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 13
• 238000003786 synthesis reaction Methods 0.000 description 13
• 238000012360 testing method Methods 0.000 description 13
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
• 239000012074 organic phase Substances 0.000 description 12
• 239000011734 sodium Substances 0.000 description 12
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 11
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
• 125000004093 cyano group Chemical group *C#N 0.000 description 11
• ZRMJQLUSQXZDCW-FQEVSTJZSA-N C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)CC(=O)NCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)CC(=O)NCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1 ZRMJQLUSQXZDCW-FQEVSTJZSA-N 0.000 description 10
• NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 10
• 238000003776 cleavage reaction Methods 0.000 description 10
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
• 230000007017 scission Effects 0.000 description 10
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• 150000001412 amines Chemical class 0.000 description 9
• 150000005840 aryl radicals Chemical class 0.000 description 9
• 230000008878 coupling Effects 0.000 description 9
• 238000010168 coupling process Methods 0.000 description 9
• 238000005859 coupling reaction Methods 0.000 description 9
• 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 8
• 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 8
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
• 239000012317 TBTU Substances 0.000 description 8
• CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 8
• 210000001772 blood platelet Anatomy 0.000 description 8
• 150000001732 carboxylic acid derivatives Chemical class 0.000 description 8
• YDNLNVZZTACNJX-UHFFFAOYSA-N isocyanatomethylbenzene Chemical compound O=C=NCC1=CC=CC=C1 YDNLNVZZTACNJX-UHFFFAOYSA-N 0.000 description 8
• 239000000047 product Substances 0.000 description 8
• 239000002904 solvent Substances 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 7
• 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 7
• 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 7
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 7
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 7
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
• 229910052801 chlorine Inorganic materials 0.000 description 7
• 150000002148 esters Chemical class 0.000 description 7
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 7
• 239000003446 ligand Substances 0.000 description 7
• 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
• 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 6
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
• 102000003992 Peroxidases Human genes 0.000 description 6
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
• 150000001408 amides Chemical group 0.000 description 6
• 230000008030 elimination Effects 0.000 description 6
• 238000003379 elimination reaction Methods 0.000 description 6
• 229910052731 fluorine Inorganic materials 0.000 description 6
• 125000001072 heteroaryl group Chemical group 0.000 description 6
• 239000012442 inert solvent Substances 0.000 description 6
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
• 238000010647 peptide synthesis reaction Methods 0.000 description 6
• 108040007629 peroxidase activity proteins Proteins 0.000 description 6
• UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 6
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
• 239000000758 substrate Substances 0.000 description 6
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
• 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 5
• 108010049003 Fibrinogen Proteins 0.000 description 5
• 102000008946 Fibrinogen Human genes 0.000 description 5
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 5
• RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 5
• 125000000217 alkyl group Chemical group 0.000 description 5
• 239000008346 aqueous phase Substances 0.000 description 5
• 239000012131 assay buffer Substances 0.000 description 5
• 239000000872 buffer Substances 0.000 description 5
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 5
• 238000001035 drying Methods 0.000 description 5
• 229940012952 fibrinogen Drugs 0.000 description 5
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
• 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 4
• ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
• 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 4
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 4
• 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 4
• KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 4
• CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 4
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
• OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
• 206010027476 Metastases Diseases 0.000 description 4
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
• IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
• 229920001213 Polysorbate 20 Polymers 0.000 description 4
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
• 108010031318 Vitronectin Proteins 0.000 description 4
• 102100035140 Vitronectin Human genes 0.000 description 4
• 150000007513 acids Chemical class 0.000 description 4
• 235000004279 alanine Nutrition 0.000 description 4
• 150000001298 alcohols Chemical class 0.000 description 4
• HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 4
• 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 4
• 150000001576 beta-amino acids Chemical class 0.000 description 4
• 229910052794 bromium Inorganic materials 0.000 description 4
• 235000013877 carbamide Nutrition 0.000 description 4
• 229910052799 carbon Inorganic materials 0.000 description 4
• 239000003153 chemical reaction reagent Substances 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 230000018109 developmental process Effects 0.000 description 4
• 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
• 238000001704 evaporation Methods 0.000 description 4
• 230000008020 evaporation Effects 0.000 description 4
• 238000004108 freeze drying Methods 0.000 description 4
• 239000012362 glacial acetic acid Substances 0.000 description 4
• 229910052740 iodine Inorganic materials 0.000 description 4
• 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 4
• 235000013336 milk Nutrition 0.000 description 4
• 239000008267 milk Substances 0.000 description 4
• 210000004080 milk Anatomy 0.000 description 4
• LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 4
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
• 108090000623 proteins and genes Proteins 0.000 description 4
• 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
• 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
• 208000019553 vascular disease Diseases 0.000 description 4
• 125000005919 1,2,2-trimethylpropyl group Chemical group 0.000 description 3
• 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 3
• 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 3
• 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 3
• 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 3
• 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 3
• KAUTWCRUPICGMP-UHFFFAOYSA-N 3-[[2-[[2-(benzylcarbamoylamino)-1,3-oxazole-5-carbonyl]amino]acetyl]amino]-3-pyridin-3-ylpropanoic acid Chemical compound C=1C=CN=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(O1)=CN=C1NC(=O)NCC1=CC=CC=C1 KAUTWCRUPICGMP-UHFFFAOYSA-N 0.000 description 3
• 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 3
• 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 3
• 125000006050 3-methyl-2-pentenyl group Chemical group 0.000 description 3
• 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
• FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
• WECZHQYTJHRMFV-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C WECZHQYTJHRMFV-UHFFFAOYSA-N 0.000 description 3
• CVRZBUMKXOKVGG-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N1)C(=O)NCC(=O)NC(CC(=O)O)C1=CC2=CC=CC=C2C=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N1)C(=O)NCC(=O)NC(CC(=O)O)C1=CC2=CC=CC=C2C=C1 CVRZBUMKXOKVGG-UHFFFAOYSA-N 0.000 description 3
• YIFVZCAGHMVGJN-UHFFFAOYSA-N CC([O-])=O.Cn1cc(NC(=O)NCc2ccccc2)cc1C(=O)NCC(=O)NC(CC(O)=O)c1ccc[nH+]c1 Chemical compound CC([O-])=O.Cn1cc(NC(=O)NCc2ccccc2)cc1C(=O)NCC(=O)NC(CC(O)=O)c1ccc[nH+]c1 YIFVZCAGHMVGJN-UHFFFAOYSA-N 0.000 description 3
• 208000024172 Cardiovascular disease Diseases 0.000 description 3
• 206010061218 Inflammation Diseases 0.000 description 3
• 102000002274 Matrix Metalloproteinases Human genes 0.000 description 3
• 108010000684 Matrix Metalloproteinases Proteins 0.000 description 3
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• 229910052783 alkali metal Inorganic materials 0.000 description 3
• 150000001340 alkali metals Chemical class 0.000 description 3
• 229910052784 alkaline earth metal Inorganic materials 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 3
• 239000004202 carbamide Substances 0.000 description 3
• 150000001735 carboxylic acids Chemical class 0.000 description 3
• 239000003054 catalyst Substances 0.000 description 3
• 238000001311 chemical methods and process Methods 0.000 description 3
• 238000004587 chromatography analysis Methods 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
• XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
• 150000002170 ethers Chemical class 0.000 description 3
• 239000000706 filtrate Substances 0.000 description 3
• 238000001914 filtration Methods 0.000 description 3
• 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
• 238000007327 hydrogenolysis reaction Methods 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 230000004054 inflammatory process Effects 0.000 description 3
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
• 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 3
• 239000012452 mother liquor Substances 0.000 description 3
• 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• 210000002997 osteoclast Anatomy 0.000 description 3
• 229910052760 oxygen Inorganic materials 0.000 description 3
• 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 3
• 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
• 230000004962 physiological condition Effects 0.000 description 3
• 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• 235000019260 propionic acid Nutrition 0.000 description 3
• 235000018102 proteins Nutrition 0.000 description 3
• 102000004169 proteins and genes Human genes 0.000 description 3
• 125000004942 pyridazin-6-yl group Chemical group N1=NC=CC=C1* 0.000 description 3
• 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 239000007858 starting material Substances 0.000 description 3
• 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
• RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
• 210000001519 tissue Anatomy 0.000 description 3
• 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 3
• 230000004614 tumor growth Effects 0.000 description 3
• BVFMJXNUCPGEIP-FQEVSTJZSA-N (2s)-3-[3-[[5-(benzylcarbamoylamino)thiophene-2-carbonyl]amino]propanoylamino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)NC(=O)CCNC(=O)C(S1)=CC=C1NC(=O)NCC1=CC=CC=C1 BVFMJXNUCPGEIP-FQEVSTJZSA-N 0.000 description 2
• ZMVBGJMBSDZOLI-SFHVURJKSA-N (2s)-3-[[2-[[2-(benzylcarbamoylamino)-1,3-oxazole-5-carbonyl]amino]acetyl]amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)NC(=O)CNC(=O)C(O1)=CN=C1NC(=O)NCC1=CC=CC=C1 ZMVBGJMBSDZOLI-SFHVURJKSA-N 0.000 description 2
• IVWXOXGKBZTJSX-SFHVURJKSA-N (2s)-3-[[2-[[2-(benzylcarbamoylamino)-1,3-thiazole-4-carbonyl]amino]acetyl]amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)NC(=O)CNC(=O)C(N=1)=CSC=1NC(=O)NCC1=CC=CC=C1 IVWXOXGKBZTJSX-SFHVURJKSA-N 0.000 description 2
• LDIQFQWJORITBJ-QFIPXVFZSA-N (2s)-3-[[2-[[4-(benzylcarbamoylamino)-1-methylpyrrole-2-carbonyl]-methylamino]acetyl]amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound N([C@@H](CNC(=O)CN(C)C(=O)C=1N(C=C(NC(=O)NCC=2C=CC=CC=2)C=1)C)C(O)=O)C(=O)OCC1=CC=CC=C1 LDIQFQWJORITBJ-QFIPXVFZSA-N 0.000 description 2
• 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
• 125000006079 1,1,2-trimethyl-2-propenyl group Chemical group 0.000 description 2
• 125000006059 1,1-dimethyl-2-butenyl group Chemical group 0.000 description 2
• 125000006033 1,1-dimethyl-2-propenyl group Chemical group 0.000 description 2
• 125000006060 1,1-dimethyl-3-butenyl group Chemical group 0.000 description 2
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
• 125000006062 1,2-dimethyl-2-butenyl group Chemical group 0.000 description 2
• 125000006035 1,2-dimethyl-2-propenyl group Chemical group 0.000 description 2
• 125000006063 1,2-dimethyl-3-butenyl group Chemical group 0.000 description 2
• KATOLVAXCGIBLO-UHFFFAOYSA-N 1,3-dibenzylurea Chemical compound C=1C=CC=CC=1CNC(=O)NCC1=CC=CC=C1 KATOLVAXCGIBLO-UHFFFAOYSA-N 0.000 description 2
• 125000006065 1,3-dimethyl-2-butenyl group Chemical group 0.000 description 2
• 125000006066 1,3-dimethyl-3-butenyl group Chemical group 0.000 description 2
• 125000006080 1-ethyl-1-methyl-2-propenyl group Chemical group 0.000 description 2
• 125000006074 1-ethyl-2-butenyl group Chemical group 0.000 description 2
• 125000006037 1-ethyl-2-propenyl group Chemical group 0.000 description 2
• 125000006075 1-ethyl-3-butenyl group Chemical group 0.000 description 2
• 125000006218 1-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 2
• 125000006028 1-methyl-2-butenyl group Chemical group 0.000 description 2
• 125000006048 1-methyl-2-pentenyl group Chemical group 0.000 description 2
• 125000006021 1-methyl-2-propenyl group Chemical group 0.000 description 2
• 125000006030 1-methyl-3-butenyl group Chemical group 0.000 description 2
• 125000006055 1-methyl-4-pentenyl group Chemical group 0.000 description 2
• YSFQIJDACSFIOH-UHFFFAOYSA-N 2,2-diaminopropanoic acid Chemical class CC(N)(N)C(O)=O YSFQIJDACSFIOH-UHFFFAOYSA-N 0.000 description 2
• 125000006069 2,3-dimethyl-2-butenyl group Chemical group 0.000 description 2
• 125000006070 2,3-dimethyl-3-butenyl group Chemical group 0.000 description 2
• NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 2
• OCZSTRUXDUIHAL-UHFFFAOYSA-N 2-(benzylcarbamoylamino)-1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC(NC(=O)NCC=2C=CC=CC=2)=N1 OCZSTRUXDUIHAL-UHFFFAOYSA-N 0.000 description 2
• TYRGLVWXHJRKMT-UHFFFAOYSA-N 2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound OC(=O)C(C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-UHFFFAOYSA-N 0.000 description 2
• XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
• GSYKNLXRWYWZAT-UHFFFAOYSA-N 2-[2-(benzylcarbamoylamino)-1,3-thiazol-4-yl]acetic acid Chemical compound OC(=O)CC1=CSC(NC(=O)NCC=2C=CC=CC=2)=N1 GSYKNLXRWYWZAT-UHFFFAOYSA-N 0.000 description 2
• 125000006078 2-ethyl-3-butenyl group Chemical group 0.000 description 2
• 125000006040 2-hexenyl group Chemical group 0.000 description 2
• 125000006029 2-methyl-2-butenyl group Chemical group 0.000 description 2
• 125000006049 2-methyl-2-pentenyl group Chemical group 0.000 description 2
• 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 2
• 125000006056 2-methyl-4-pentenyl group Chemical group 0.000 description 2
• JIZRGGUCOQKGQD-UHFFFAOYSA-N 2-nitrothiophene Chemical compound [O-][N+](=O)C1=CC=CS1 JIZRGGUCOQKGQD-UHFFFAOYSA-N 0.000 description 2
• 125000006024 2-pentenyl group Chemical group 0.000 description 2
• 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 2
• YSYYJJWVNKORRS-UHFFFAOYSA-N 3-[3-[[4-(benzylcarbamoylamino)-1-methylpyrrole-2-carbonyl]amino]propanoylamino]-3-pyridin-3-ylpropanoic acid Chemical compound C1=C(C(=O)NCCC(=O)NC(CC(O)=O)C=2C=NC=CC=2)N(C)C=C1NC(=O)NCC1=CC=CC=C1 YSYYJJWVNKORRS-UHFFFAOYSA-N 0.000 description 2
• XEVNETHTGZYGEY-UHFFFAOYSA-N 3-[[2-[[2-(benzylcarbamoylamino)-1,3-oxazole-4-carbonyl]amino]acetyl]amino]-3-pyridin-3-ylpropanoic acid Chemical compound C=1C=CN=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(N=1)=COC=1NC(=O)NCC1=CC=CC=C1 XEVNETHTGZYGEY-UHFFFAOYSA-N 0.000 description 2
• IHJDDZUSFQGHNY-UHFFFAOYSA-N 3-[[2-[[2-(benzylcarbamoylamino)-1,3-oxazole-5-carbonyl]amino]acetyl]amino]-3-(3,5-dichlorophenyl)propanoic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(O1)=CN=C1NC(=O)NCC1=CC=CC=C1 IHJDDZUSFQGHNY-UHFFFAOYSA-N 0.000 description 2
• FNQGLKRCVLOEOI-UHFFFAOYSA-N 3-[[2-[[4-(benzylcarbamoylamino)-1-methylpyrrole-2-carbonyl]amino]acetyl]amino]-3-naphthalen-2-ylpropanoic acid Chemical compound C1=C(C(=O)NCC(=O)NC(CC(O)=O)C=2C=C3C=CC=CC3=CC=2)N(C)C=C1NC(=O)NCC1=CC=CC=C1 FNQGLKRCVLOEOI-UHFFFAOYSA-N 0.000 description 2
• DCIXVMLLSRDBCL-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-2-carbonyl]amino]acetyl]amino]-3-(2,5-dimethoxyphenyl)propanoic acid Chemical compound COC1=CC=C(OC)C(C(CC(O)=O)NC(=O)CNC(=O)C=2SC(NC(=O)NCC=3C=CC=CC=3)=CC=2)=C1 DCIXVMLLSRDBCL-UHFFFAOYSA-N 0.000 description 2
• HNQGBAOSEITQQT-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-2-carbonyl]amino]acetyl]amino]-3-(3,4-dimethoxyphenyl)propanoic acid Chemical compound C1=C(OC)C(OC)=CC=C1C(CC(O)=O)NC(=O)CNC(=O)C(S1)=CC=C1NC(=O)NCC1=CC=CC=C1 HNQGBAOSEITQQT-UHFFFAOYSA-N 0.000 description 2
• BLYATQCVCKGGPT-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-2-carbonyl]amino]acetyl]amino]-3-naphthalen-1-ylpropanoic acid Chemical compound C=1C=CC2=CC=CC=C2C=1C(CC(=O)O)NC(=O)CNC(=O)C(S1)=CC=C1NC(=O)NCC1=CC=CC=C1 BLYATQCVCKGGPT-UHFFFAOYSA-N 0.000 description 2
• WQEAUYPJMRZAST-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-3-carbonyl]amino]acetyl]amino]-3-(3,5-dichlorophenyl)propanoic acid Chemical compound C=1C(Cl)=CC(Cl)=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(C=1)=CSC=1NC(=O)NCC1=CC=CC=C1 WQEAUYPJMRZAST-UHFFFAOYSA-N 0.000 description 2
• LTAQWGJIAOYYEJ-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-3-carbonyl]amino]acetyl]amino]-3-(4-methylphenyl)propanoic acid Chemical compound C1=CC(C)=CC=C1C(CC(O)=O)NC(=O)CNC(=O)C1=CSC(NC(=O)NCC=2C=CC=CC=2)=C1 LTAQWGJIAOYYEJ-UHFFFAOYSA-N 0.000 description 2
• GITHMVUAHBUYNI-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-3-carbonyl]amino]acetyl]amino]-3-pyridin-3-ylpropanoic acid Chemical compound C=1C=CN=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(C=1)=CSC=1NC(=O)NCC1=CC=CC=C1 GITHMVUAHBUYNI-UHFFFAOYSA-N 0.000 description 2
• 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 2
• 125000006041 3-hexenyl group Chemical group 0.000 description 2
• 125000006032 3-methyl-3-butenyl group Chemical group 0.000 description 2
• 125000006054 3-methyl-3-pentenyl group Chemical group 0.000 description 2
• 125000006057 3-methyl-4-pentenyl group Chemical group 0.000 description 2
• 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• 125000006042 4-hexenyl group Chemical group 0.000 description 2
• 125000006051 4-methyl-2-pentenyl group Chemical group 0.000 description 2
• 125000003119 4-methyl-3-pentenyl group Chemical group [H]\C(=C(/C([H])([H])[H])C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
• 125000006058 4-methyl-4-pentenyl group Chemical group 0.000 description 2
• 125000006043 5-hexenyl group Chemical group 0.000 description 2
• KYARBIJYVGJZLB-UHFFFAOYSA-N 7-amino-4-hydroxy-2-naphthalenesulfonic acid Chemical group OC1=CC(S(O)(=O)=O)=CC2=CC(N)=CC=C21 KYARBIJYVGJZLB-UHFFFAOYSA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
• USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
• 239000005695 Ammonium acetate Substances 0.000 description 2
• NHXSXAWFKOWPGI-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C1=CC=CC=C1 NHXSXAWFKOWPGI-UHFFFAOYSA-N 0.000 description 2
• DPZDDBRERDSVMF-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NC(CC(=O)O)C1CCCCC1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NC(CC(=O)O)C1CCCCC1 DPZDDBRERDSVMF-UHFFFAOYSA-N 0.000 description 2
• MOJNHFGHMLRFJJ-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NC(CC(=O)O)C=1C=NC=CC1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NC(CC(=O)O)C=1C=NC=CC1 MOJNHFGHMLRFJJ-UHFFFAOYSA-N 0.000 description 2
• PJFPIEGKRHXYRZ-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)NCCC(=O)NC(CC(=O)O)C1CCCCC1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)NCCC(=O)NC(CC(=O)O)C1CCCCC1 PJFPIEGKRHXYRZ-UHFFFAOYSA-N 0.000 description 2
• VODWYCYDJAOEGL-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)NCCC(=O)NC(CC(=O)O)C=1C=NC=CC=1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)NCCC(=O)NC(CC(=O)O)C=1C=NC=CC=1 VODWYCYDJAOEGL-UHFFFAOYSA-N 0.000 description 2
• DSFLVQKKKBGGIZ-ZZWBGTBQSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N[C@@H](C(=O)NC(CC(=O)O)C1=CC=C(C=C1)C(C)(C)C)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N[C@@H](C(=O)NC(CC(=O)O)C1=CC=C(C=C1)C(C)(C)C)C DSFLVQKKKBGGIZ-ZZWBGTBQSA-N 0.000 description 2
• DSFLVQKKKBGGIZ-HXBUSHRASA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N[C@H](C(=O)NC(CC(=O)O)C1=CC=C(C=C1)C(C)(C)C)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N[C@H](C(=O)NC(CC(=O)O)C1=CC=C(C=C1)C(C)(C)C)C DSFLVQKKKBGGIZ-HXBUSHRASA-N 0.000 description 2
• DUIXNWGIJUVLKZ-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC2=CC=CC=C2C=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC2=CC=CC=C2C=C1 DUIXNWGIJUVLKZ-UHFFFAOYSA-N 0.000 description 2
• ZOTXUVGEVRIEBL-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C ZOTXUVGEVRIEBL-UHFFFAOYSA-N 0.000 description 2
• GJOOHTUKHNLNMU-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C1=CC=CC=C1 GJOOHTUKHNLNMU-UHFFFAOYSA-N 0.000 description 2
• GLIFBFFKWURDFZ-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=CC2=CC=CC=C12 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1=CC=CC2=CC=CC=C12 GLIFBFFKWURDFZ-UHFFFAOYSA-N 0.000 description 2
• XNOMNWRWDSVJGH-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C=1C=NC=CC1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C=1C=NC=CC1 XNOMNWRWDSVJGH-UHFFFAOYSA-N 0.000 description 2
• BAIQNBWCAKKOQA-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1CCCCC1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1CCCCC1 BAIQNBWCAKKOQA-UHFFFAOYSA-N 0.000 description 2
• PTNIAPRVCXSGTG-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCCC(=O)NC(CC(=O)O)C1=C(C=CC(=C1)OC)OC Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCCC(=O)NC(CC(=O)O)C1=C(C=CC(=C1)OC)OC PTNIAPRVCXSGTG-UHFFFAOYSA-N 0.000 description 2
• JIVPNEROKWDAEG-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N1)C(=O)NCC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N1)C(=O)NCC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C JIVPNEROKWDAEG-UHFFFAOYSA-N 0.000 description 2
• CCKWYMHBRBKPLC-LPHOPBHVSA-N C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)C(=O)N[C@H](C(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)C(=O)N[C@H](C(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1)C CCKWYMHBRBKPLC-LPHOPBHVSA-N 0.000 description 2
• JAEUOEXFAUZZMD-UWJYYQICSA-N C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)CC(=O)N[C@H](C(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)CC(=O)N[C@H](C(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1)C JAEUOEXFAUZZMD-UWJYYQICSA-N 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
• ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 102000016359 Fibronectins Human genes 0.000 description 2
• 206010019280 Heart failures Diseases 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 241000242362 Kordia Species 0.000 description 2
• 238000005684 Liebig rearrangement reaction Methods 0.000 description 2
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
• LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
• 208000034827 Neointima Diseases 0.000 description 2
• 206010029113 Neovascularisation Diseases 0.000 description 2
• CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 208000010191 Osteitis Deformans Diseases 0.000 description 2
• 208000027868 Paget disease Diseases 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
• 108060008245 Thrombospondin Proteins 0.000 description 2
• 102000002938 Thrombospondin Human genes 0.000 description 2
• XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 2
• 239000003875 Wang resin Substances 0.000 description 2
• NERFNHBZJXXFGY-UHFFFAOYSA-N [4-[(4-methylphenyl)methoxy]phenyl]methanol Chemical compound C1=CC(C)=CC=C1COC1=CC=C(CO)C=C1 NERFNHBZJXXFGY-UHFFFAOYSA-N 0.000 description 2
• 238000011481 absorbance measurement Methods 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 2
• 150000001342 alkaline earth metals Chemical class 0.000 description 2
• RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• 229940043376 ammonium acetate Drugs 0.000 description 2
• 235000019257 ammonium acetate Nutrition 0.000 description 2
• 150000008064 anhydrides Chemical class 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 230000002141 anti-parasite Effects 0.000 description 2
• 230000000840 anti-viral effect Effects 0.000 description 2
• 239000003096 antiparasitic agent Substances 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000001580 bacterial effect Effects 0.000 description 2
• 239000002585 base Substances 0.000 description 2
• WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 230000037396 body weight Effects 0.000 description 2
• 210000002805 bone matrix Anatomy 0.000 description 2
• 210000004899 c-terminal region Anatomy 0.000 description 2
• 229910052791 calcium Inorganic materials 0.000 description 2
• 239000011575 calcium Substances 0.000 description 2
• CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 229950005499 carbon tetrachloride Drugs 0.000 description 2
• 230000001413 cellular effect Effects 0.000 description 2
• 239000011248 coating agent Substances 0.000 description 2
• 238000000576 coating method Methods 0.000 description 2
• 238000001816 cooling Methods 0.000 description 2
• 125000000753 cycloalkyl group Chemical group 0.000 description 2
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• 210000002889 endothelial cell Anatomy 0.000 description 2
• 125000000524 functional group Chemical group 0.000 description 2
• 230000007062 hydrolysis Effects 0.000 description 2
• 238000006460 hydrolysis reaction Methods 0.000 description 2
• AKPUJVVHYUHGKY-UHFFFAOYSA-N hydron;propan-2-ol;chloride Chemical compound Cl.CC(C)O AKPUJVVHYUHGKY-UHFFFAOYSA-N 0.000 description 2
• 125000002883 imidazolyl group Chemical group 0.000 description 2
• 230000001771 impaired effect Effects 0.000 description 2
• 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 2
• 150000002576 ketones Chemical class 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• 210000002540 macrophage Anatomy 0.000 description 2
• 230000003211 malignant effect Effects 0.000 description 2
• 208000027202 mammary Paget disease Diseases 0.000 description 2
• 230000001394 metastastic effect Effects 0.000 description 2
• 206010061289 metastatic neoplasm Diseases 0.000 description 2
• 150000004702 methyl esters Chemical class 0.000 description 2
• TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000014399 negative regulation of angiogenesis Effects 0.000 description 2
• 230000008692 neointimal formation Effects 0.000 description 2
• 150000002825 nitriles Chemical class 0.000 description 2
• 150000002828 nitro derivatives Chemical class 0.000 description 2
• LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
• 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 2
• 239000001301 oxygen Substances 0.000 description 2
• FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 2
• 230000020477 pH reduction Effects 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
• 239000003208 petroleum Substances 0.000 description 2
• 239000012071 phase Substances 0.000 description 2
• 229920000642 polymer Polymers 0.000 description 2
• 229910052700 potassium Inorganic materials 0.000 description 2
• 239000011591 potassium Substances 0.000 description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 2
• 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 238000000746 purification Methods 0.000 description 2
• 125000003226 pyrazolyl group Chemical group 0.000 description 2
• 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 2
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
• 125000000168 pyrrolyl group Chemical group 0.000 description 2
• 239000011541 reaction mixture Substances 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 239000000741 silica gel Substances 0.000 description 2
• 229910002027 silica gel Inorganic materials 0.000 description 2
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 238000003756 stirring Methods 0.000 description 2
• 150000003462 sulfoxides Chemical class 0.000 description 2
• 239000000725 suspension Substances 0.000 description 2
• VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• GLQWRXYOTXRDNH-UHFFFAOYSA-N thiophen-2-amine Chemical compound NC1=CC=CS1 GLQWRXYOTXRDNH-UHFFFAOYSA-N 0.000 description 2
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
• 125000001425 triazolyl group Chemical group 0.000 description 2
• UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 2
• 238000001665 trituration Methods 0.000 description 2
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
• 229920002554 vinyl polymer Polymers 0.000 description 2
• 239000008096 xylene Substances 0.000 description 2
• FMCAFXHLMUOIGG-JTJHWIPRSA-N (2s)-2-[[(2r)-2-[[(2s)-2-[[(2r)-2-formamido-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxy-2,5-dimethylphenyl)propanoyl]amino]-4-methylsulfanylbutanoic acid Chemical compound O=CN[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(=O)N[C@@H](CCSC)C(O)=O)CC1=CC(C)=C(O)C=C1C FMCAFXHLMUOIGG-JTJHWIPRSA-N 0.000 description 1
• PDRJLZDUOULRHE-ZETCQYMHSA-N (2s)-2-amino-3-pyridin-2-ylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=N1 PDRJLZDUOULRHE-ZETCQYMHSA-N 0.000 description 1
• MZJMMZBHRMYGQE-NRFANRHFSA-N (2s)-3-[[2-[[4-(benzylcarbamoylamino)-1-methylpyrrole-2-carbonyl]amino]acetyl]amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C1=C(C(=O)NCC(=O)NC[C@H](NC(=O)OCC=2C=CC=CC=2)C(O)=O)N(C)C=C1NC(=O)NCC1=CC=CC=C1 MZJMMZBHRMYGQE-NRFANRHFSA-N 0.000 description 1
• IEFPFWXCTNNSQN-FQEVSTJZSA-N (2s)-3-[[2-[[5-(benzylcarbamoylamino)furan-2-carbonyl]-methylamino]acetyl]amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound N([C@@H](CNC(=O)CN(C)C(=O)C=1OC(NC(=O)NCC=2C=CC=CC=2)=CC=1)C(O)=O)C(=O)OCC1=CC=CC=C1 IEFPFWXCTNNSQN-FQEVSTJZSA-N 0.000 description 1
• QXXVTZTYGKZSOS-IBGZPJMESA-N (2s)-3-[[2-[[5-(benzylcarbamoylamino)thiophene-2-carbonyl]amino]acetyl]amino]-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)OCC=1C=CC=CC=1)NC(=O)CNC(=O)C(S1)=CC=C1NC(=O)NCC1=CC=CC=C1 QXXVTZTYGKZSOS-IBGZPJMESA-N 0.000 description 1
• ZRVZOBGMZWVJOS-VMXHOPILSA-N (2s)-6-amino-2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[2-[[(2s)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN ZRVZOBGMZWVJOS-VMXHOPILSA-N 0.000 description 1
• RHBJBHPMIXWECR-OAQYLSRUSA-N (3r)-4-[[2-[[5-(benzylcarbamoylamino)furan-2-carbonyl]-methylamino]acetyl]amino]-3-(phenylmethoxycarbonylamino)butanoic acid Chemical compound N([C@H](CC(O)=O)CNC(=O)CN(C)C(=O)C=1OC(NC(=O)NCC=2C=CC=CC=2)=CC=1)C(=O)OCC1=CC=CC=C1 RHBJBHPMIXWECR-OAQYLSRUSA-N 0.000 description 1
• 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
• FIARMZDBEGVMLV-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanolate Chemical group [O-]C(F)(F)C(F)(F)F FIARMZDBEGVMLV-UHFFFAOYSA-N 0.000 description 1
• DHBXNPKRAUYBTH-UHFFFAOYSA-N 1,1-ethanedithiol Chemical compound CC(S)S DHBXNPKRAUYBTH-UHFFFAOYSA-N 0.000 description 1
• JFLSOKIMYBSASW-UHFFFAOYSA-N 1-chloro-2-[chloro(diphenyl)methyl]benzene Chemical compound ClC1=CC=CC=C1C(Cl)(C=1C=CC=CC=1)C1=CC=CC=C1 JFLSOKIMYBSASW-UHFFFAOYSA-N 0.000 description 1
• 125000006082 1-ethyl-2-methyl-2-propenyl group Chemical group 0.000 description 1
• 125000004790 1-fluoroethoxy group Chemical group FC(C)O* 0.000 description 1
• 238000005160 1H NMR spectroscopy Methods 0.000 description 1
• LJVQHXICFCZRJN-UHFFFAOYSA-N 1h-1,2,4-triazole-5-carboxylic acid Chemical compound OC(=O)C1=NC=NN1 LJVQHXICFCZRJN-UHFFFAOYSA-N 0.000 description 1
• 125000006067 2,2-dimethyl-3-butenyl group Chemical group 0.000 description 1
• BPKYIPMIYKDNDX-UHFFFAOYSA-N 2-(benzylcarbamoylamino)-1,3-oxazole-4-carboxylic acid Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N=1)C(=O)O BPKYIPMIYKDNDX-UHFFFAOYSA-N 0.000 description 1
• SMMIXYLWADEUHD-UHFFFAOYSA-N 2-(benzylcarbamoylamino)-1,3-oxazole-5-carboxylic acid Chemical compound O1C(C(=O)O)=CN=C1NC(=O)NCC1=CC=CC=C1 SMMIXYLWADEUHD-UHFFFAOYSA-N 0.000 description 1
• CZIBABWRWDOXIT-UHFFFAOYSA-N 2-(benzylsulfonylamino)propanoic acid Chemical compound OC(=O)C(C)NS(=O)(=O)CC1=CC=CC=C1 CZIBABWRWDOXIT-UHFFFAOYSA-N 0.000 description 1
• GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
• WEDLPAQWIONWGX-UHFFFAOYSA-N 2-(naphthalen-1-ylsulfonylamino)propanoic acid Chemical compound C1=CC=C2C(S(=O)(=O)NC(C)C(O)=O)=CC=CC2=C1 WEDLPAQWIONWGX-UHFFFAOYSA-N 0.000 description 1
• WDEXFHHXWOSJRV-UHFFFAOYSA-N 2-(naphthalen-2-ylsulfonylamino)propanoic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)NC(C)C(O)=O)=CC=C21 WDEXFHHXWOSJRV-UHFFFAOYSA-N 0.000 description 1
• JJBCTCGUOQYZHK-UHFFFAOYSA-N 2-acetyloxybenzoate;(5-amino-1-carboxypentyl)azanium Chemical compound OC(=O)C(N)CCCC[NH3+].CC(=O)OC1=CC=CC=C1C([O-])=O JJBCTCGUOQYZHK-UHFFFAOYSA-N 0.000 description 1
• SXRKNKLAGDXHDA-UHFFFAOYSA-N 2-bromoethyl 2-oxopropanoate Chemical compound CC(=O)C(=O)OCCBr SXRKNKLAGDXHDA-UHFFFAOYSA-N 0.000 description 1
• 125000006077 2-ethyl-2-butenyl group Chemical group 0.000 description 1
• 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
• 125000006031 2-methyl-3-butenyl group Chemical group 0.000 description 1
• 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
• 125000006188 2-phenyl benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 description 1
• 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 description 1
• YKIPCMAQZHPCHW-UHFFFAOYSA-N 3-(benzylcarbamoylamino)-1H-1,2,4-triazole-5-carboxylic acid Chemical compound OC(=O)c1nc(NC(=O)NCc2ccccc2)n[nH]1 YKIPCMAQZHPCHW-UHFFFAOYSA-N 0.000 description 1
• KDSSSTJCIAYSLL-UHFFFAOYSA-N 3-[[2-[[2-(benzylcarbamoylamino)-1,3-thiazole-5-carbonyl]amino]acetyl]amino]-3-pyridin-3-ylpropanoic acid Chemical compound C=1C=CN=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(S1)=CN=C1NC(=O)NCC1=CC=CC=C1 KDSSSTJCIAYSLL-UHFFFAOYSA-N 0.000 description 1
• SPEGLASITQIUHE-UHFFFAOYSA-N 3-[[2-[[5-(benzylcarbamoylamino)thiophene-2-carbonyl]amino]acetyl]amino]-3-pyridin-3-ylpropanoic acid Chemical compound C=1C=CN=CC=1C(CC(=O)O)NC(=O)CNC(=O)C(S1)=CC=C1NC(=O)NCC1=CC=CC=C1 SPEGLASITQIUHE-UHFFFAOYSA-N 0.000 description 1
• XQIGCIKMXNANJT-UHFFFAOYSA-N 3-amino-1,2,4-triazole-3-carboxylic acid Chemical compound OC(=O)C1(N)N=CN=N1 XQIGCIKMXNANJT-UHFFFAOYSA-N 0.000 description 1
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
• 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
• APTHSBLGVMYQRL-UHFFFAOYSA-N 4-amino-1h-pyrrole-2-carboxylic acid Chemical compound NC1=CNC(C(O)=O)=C1 APTHSBLGVMYQRL-UHFFFAOYSA-N 0.000 description 1
• ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
• 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• QEDKLMLRTUCIOX-UHFFFAOYSA-N 5-(benzylcarbamoylamino)furan-2-carboxylic acid Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(O1)C(=O)O QEDKLMLRTUCIOX-UHFFFAOYSA-N 0.000 description 1
• URBZWDMDTMKBKW-UHFFFAOYSA-N 5-(benzylcarbamoylamino)thiophene-2-carboxylic acid Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)O URBZWDMDTMKBKW-UHFFFAOYSA-N 0.000 description 1
• UYTYLLQCQDBCDW-UHFFFAOYSA-N 5-amino-2-methylpyrazole-3-carboxylic acid Chemical compound CN1N=C(N)C=C1C(O)=O UYTYLLQCQDBCDW-UHFFFAOYSA-N 0.000 description 1
• PPKYDYFPGZQNFM-UHFFFAOYSA-N 5-amino-2h-1,3,4-thiadiazole-5-carboxylic acid Chemical compound OC(=O)C1(N)SCN=N1 PPKYDYFPGZQNFM-UHFFFAOYSA-N 0.000 description 1
• BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
• UNEPVPOHGXLUIR-UHFFFAOYSA-N 6317-37-9 Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)S1 UNEPVPOHGXLUIR-UHFFFAOYSA-N 0.000 description 1
• 102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
• 101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 description 1
• 241001116389 Aloe Species 0.000 description 1
• KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
• 102100021267 Anion exchange protein 4 Human genes 0.000 description 1
• 101710160272 Anion exchange protein 4 Proteins 0.000 description 1
• 102000005666 Apolipoprotein A-I Human genes 0.000 description 1
• 108010059886 Apolipoprotein A-I Proteins 0.000 description 1
• OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
• 102000004506 Blood Proteins Human genes 0.000 description 1
• 108010017384 Blood Proteins Proteins 0.000 description 1
• 239000004604 Blowing Agent Substances 0.000 description 1
• 208000006386 Bone Resorption Diseases 0.000 description 1
• 229940123861 Bone formation stimulant Drugs 0.000 description 1
• SVPLJYKBSNVDJK-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NCC(CC(=O)O)NC(=O)OCC1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC1=CC=C(S1)C(=O)N(C)CC(=O)NCC(CC(=O)O)NC(=O)OCC1=CC=CC=C1 SVPLJYKBSNVDJK-UHFFFAOYSA-N 0.000 description 1
• GQJHVQYYEAKHBG-HSZRJFAPSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(C(=O)NCC(=O)NC[C@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)C=CC=1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(C(=O)NCC(=O)NC[C@H](C(=O)O)NC(=O)OCC2=CC=CC=C2)C=CC=1 GQJHVQYYEAKHBG-HSZRJFAPSA-N 0.000 description 1
• SXTXSDYXGSKJMR-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1CCCCC1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)N(C)CC(=O)NC(CC(=O)O)C1CCCCC1 SXTXSDYXGSKJMR-UHFFFAOYSA-N 0.000 description 1
• DOEFWBQLZRHEEE-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC(=C(C=C1)OC)OC Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC(=C(C=C1)OC)OC DOEFWBQLZRHEEE-UHFFFAOYSA-N 0.000 description 1
• DPCPATWVJROOKV-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC(=CC(=C1)Cl)Cl Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC(=CC(=C1)Cl)Cl DPCPATWVJROOKV-UHFFFAOYSA-N 0.000 description 1
• AEOASSGYTFLRSS-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1C=C(N(C1)C)C(=O)NCC(=O)NC(CC(=O)O)C1=CC=C(C=C1)C1=CC=CC=C1 AEOASSGYTFLRSS-UHFFFAOYSA-N 0.000 description 1
• FZDMIEJRFDIKEW-SFHVURJKSA-N C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N1)C(=O)NCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1 Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1OC=C(N1)C(=O)NCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1 FZDMIEJRFDIKEW-SFHVURJKSA-N 0.000 description 1
• PEJVNSVPBNEUQV-UHFFFAOYSA-N C(C1=CC=CC=C1)NC(=O)NC=1SC(=CN1)C(=O)NCC(=O)NC(CC(=O)O)C1=C(C=CC(=C1)OC)OC Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1SC(=CN1)C(=O)NCC(=O)NC(CC(=O)O)C1=C(C=CC(=C1)OC)OC PEJVNSVPBNEUQV-UHFFFAOYSA-N 0.000 description 1
• JAEUOEXFAUZZMD-UTKZUKDTSA-N C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)CC(=O)N[C@@H](C(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1)C Chemical compound C(C1=CC=CC=C1)NC(=O)NC=1SC=C(N=1)CC(=O)N[C@@H](C(=O)NC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1)C JAEUOEXFAUZZMD-UTKZUKDTSA-N 0.000 description 1
• UWESUJDQQBSNCA-NRFANRHFSA-N C1=CC=C(C=C1)CNC(=O)NC2=CC(=CS2)C(=O)NCCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC3=CC=CC=C3 Chemical compound C1=CC=C(C=C1)CNC(=O)NC2=CC(=CS2)C(=O)NCCC(=O)NC[C@@H](C(=O)O)NC(=O)OCC3=CC=CC=C3 UWESUJDQQBSNCA-NRFANRHFSA-N 0.000 description 1
• TWIZANLIQUUSQX-FQEVSTJZSA-N C1=CC=C(C=C1)CNC(=O)NC2=CC(=CS2)C(=O)NCCC(=O)NC[C@@H](C(=O)O)NS(=O)(=O)C3=CC=CC=C3 Chemical compound C1=CC=C(C=C1)CNC(=O)NC2=CC(=CS2)C(=O)NCCC(=O)NC[C@@H](C(=O)O)NS(=O)(=O)C3=CC=CC=C3 TWIZANLIQUUSQX-FQEVSTJZSA-N 0.000 description 1
• UCMLYXQCGSSOQD-LJQANCHMSA-N C1=CC=C(C=C1)CNC(=O)NC2=NNC(=N2)C(=O)NCCC(=O)NC[C@@H](CC(=O)O)NC(=O)OCC3=CC=CC=C3 Chemical compound C1=CC=C(C=C1)CNC(=O)NC2=NNC(=N2)C(=O)NCCC(=O)NC[C@@H](CC(=O)O)NC(=O)OCC3=CC=CC=C3 UCMLYXQCGSSOQD-LJQANCHMSA-N 0.000 description 1
• 125000000882 C2-C6 alkenyl group Chemical class 0.000 description 1
• ATCBRYAUAXPURN-SFHVURJKSA-N CCCCS(=O)(=O)N[C@@H](CNC(=O)CCNC(=O)C1=CSC(=C1)NC(=O)NCC2=CC=CC=C2)C(=O)O Chemical compound CCCCS(=O)(=O)N[C@@H](CNC(=O)CCNC(=O)C1=CSC(=C1)NC(=O)NCC2=CC=CC=C2)C(=O)O ATCBRYAUAXPURN-SFHVURJKSA-N 0.000 description 1
• HHDDXIAZUZWAMX-FQEVSTJZSA-N CN(CC(=O)NC[C@@H](C(=O)O)NS(=O)(=O)C1=CC=CC=C1)C(=O)CC2=CSC(=N2)NC(=O)NCC3=CC=CC=C3 Chemical compound CN(CC(=O)NC[C@@H](C(=O)O)NS(=O)(=O)C1=CC=CC=C1)C(=O)CC2=CSC(=N2)NC(=O)NCC3=CC=CC=C3 HHDDXIAZUZWAMX-FQEVSTJZSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 108090000201 Carboxypeptidase B2 Proteins 0.000 description 1
• 102100035023 Carboxypeptidase B2 Human genes 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
• 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
• 108091006146 Channels Proteins 0.000 description 1
• 101150065749 Churc1 gene Proteins 0.000 description 1
• 241000070918 Cima Species 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
• 206010012689 Diabetic retinopathy Diseases 0.000 description 1
• 108700021041 Disintegrin Proteins 0.000 description 1
• YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
• 208000005189 Embolism Diseases 0.000 description 1
• 108010012088 Fibrinogen Receptors Proteins 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 239000007821 HATU Substances 0.000 description 1
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
• 241000545744 Hirudinea Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000803709 Homo sapiens Vitronectin Proteins 0.000 description 1
• 102000008100 Human Serum Albumin Human genes 0.000 description 1
• 108091006905 Human Serum Albumin Proteins 0.000 description 1
• 208000037147 Hypercalcaemia Diseases 0.000 description 1
• 102100025306 Integrin alpha-IIb Human genes 0.000 description 1
• 101710149643 Integrin alpha-IIb Proteins 0.000 description 1
• 102100022339 Integrin alpha-L Human genes 0.000 description 1
• 102100022337 Integrin alpha-V Human genes 0.000 description 1
• 108010028750 Integrin-Binding Sialoprotein Proteins 0.000 description 1
• 102000016921 Integrin-Binding Sialoprotein Human genes 0.000 description 1
• DGYHPLMPMRKMPD-BYPYZUCNSA-N L-propargylglycine Chemical compound OC(=O)[C@@H](N)CC#C DGYHPLMPMRKMPD-BYPYZUCNSA-N 0.000 description 1
• 102000007547 Laminin Human genes 0.000 description 1
• 108010085895 Laminin Proteins 0.000 description 1
• 241000208202 Linaceae Species 0.000 description 1
• 235000004431 Linum usitatissimum Nutrition 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 208000019693 Lung disease Diseases 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• DTOBPZXGVBQKJD-UHFFFAOYSA-N NC1(OC=CN1)C(=O)O Chemical compound NC1(OC=CN1)C(=O)O DTOBPZXGVBQKJD-UHFFFAOYSA-N 0.000 description 1
• KHUFYCSOWBSHFA-UHFFFAOYSA-N NC1=C(OC=C1)C(=O)OC(=O)NCC1=CC=CC=C1 Chemical compound NC1=C(OC=C1)C(=O)OC(=O)NCC1=CC=CC=C1 KHUFYCSOWBSHFA-UHFFFAOYSA-N 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• BYNPVIFXZBYHTL-JOCHJYFZSA-N OC(C[C@H](CNC(CCNC(C1=CSC(NC(NCC2=CC=CC=C2)=O)=C1)=O)=O)NC(OCC1=CC=CC=C1)=O)=O Chemical compound OC(C[C@H](CNC(CCNC(C1=CSC(NC(NCC2=CC=CC=C2)=O)=C1)=O)=O)NC(OCC1=CC=CC=C1)=O)=O BYNPVIFXZBYHTL-JOCHJYFZSA-N 0.000 description 1
• HMPVRYMNSVIJDI-KRWDZBQOSA-N OC([C@H](CNC(CNC(C1=NNC(NC(NCC2=CC=CC=C2)=O)=N1)=O)=O)NC(OCC1=CC=CC=C1)=O)=O Chemical compound OC([C@H](CNC(CNC(C1=NNC(NC(NCC2=CC=CC=C2)=O)=N1)=O)=O)NC(OCC1=CC=CC=C1)=O)=O HMPVRYMNSVIJDI-KRWDZBQOSA-N 0.000 description 1
• 102000004264 Osteopontin Human genes 0.000 description 1
• 108010081689 Osteopontin Proteins 0.000 description 1
• GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
• 102100038124 Plasminogen Human genes 0.000 description 1
• 108010051456 Plasminogen Proteins 0.000 description 1
• 108010022233 Plasminogen Activator Inhibitor 1 Proteins 0.000 description 1
• 102100039418 Plasminogen activator inhibitor 1 Human genes 0.000 description 1
• PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102100038239 Protein Churchill Human genes 0.000 description 1
• 229940123924 Protein kinase C inhibitor Drugs 0.000 description 1
• 102100027378 Prothrombin Human genes 0.000 description 1
• 108010094028 Prothrombin Proteins 0.000 description 1
• 206010062237 Renal impairment Diseases 0.000 description 1
• 206010063837 Reperfusion injury Diseases 0.000 description 1
• 244000191761 Sida cordifolia Species 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 108010023197 Streptokinase Proteins 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 102000007000 Tenascin Human genes 0.000 description 1
• 108010008125 Tenascin Proteins 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
• 208000001435 Thromboembolism Diseases 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
• 108010048673 Vitronectin Receptors Proteins 0.000 description 1
• BHIRTUJCQXDFRD-UHFFFAOYSA-N [Si].[P].[S] Chemical compound [Si].[P].[S] BHIRTUJCQXDFRD-UHFFFAOYSA-N 0.000 description 1
• DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
• 230000010933 acylation Effects 0.000 description 1
• 238000005917 acylation reaction Methods 0.000 description 1
• 229940062527 alendronate Drugs 0.000 description 1
• 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
• 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000003545 alkoxy group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• 235000011399 aloe vera Nutrition 0.000 description 1
• XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229960004050 aminobenzoic acid Drugs 0.000 description 1
• 238000005571 anion exchange chromatography Methods 0.000 description 1
• 230000000123 anti-resoprtive effect Effects 0.000 description 1
• 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
• 210000003719 b-lymphocyte Anatomy 0.000 description 1
• 229910052788 barium Inorganic materials 0.000 description 1
• DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
• 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
• 210000004204 blood vessel Anatomy 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 230000024279 bone resorption Effects 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 239000012267 brine Substances 0.000 description 1
• 229910052792 caesium Inorganic materials 0.000 description 1
• TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
• 229930006739 camphene Natural products 0.000 description 1
• ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 125000004432 carbon atom Chemical group C* 0.000 description 1
• 150000007942 carboxylates Chemical class 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000004663 cell proliferation Effects 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 230000035605 chemotaxis Effects 0.000 description 1
• 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
• 125000004789 chlorodifluoromethoxy group Chemical group ClC(O*)(F)F 0.000 description 1
• 210000003711 chorioallantoic membrane Anatomy 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000009833 condensation Methods 0.000 description 1
• 230000005494 condensation Effects 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 230000009260 cross reactivity Effects 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
• 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• 108010073977 decorsin Proteins 0.000 description 1
• 239000000645 desinfectant Substances 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 201000002249 diabetic peripheral angiopathy Diseases 0.000 description 1
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
• 125000005879 dioxolanyl group Chemical group 0.000 description 1
• IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
• 229960002768 dipyridamole Drugs 0.000 description 1
• 208000035475 disorder Diseases 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 238000010828 elution Methods 0.000 description 1
• 230000013020 embryo development Effects 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 238000005516 engineering process Methods 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000328 estrogen antagonist Substances 0.000 description 1
• LBAQSKZHMLAFHH-UHFFFAOYSA-N ethoxyethane;hydron;chloride Chemical compound Cl.CCOCC LBAQSKZHMLAFHH-UHFFFAOYSA-N 0.000 description 1
• AVMSETIQLSEUJA-UHFFFAOYSA-N ethyl 2-(benzylcarbamoylamino)-1,3-oxazole-4-carboxylate Chemical compound CCOC(=O)C1=COC(NC(=O)NCC=2C=CC=CC=2)=N1 AVMSETIQLSEUJA-UHFFFAOYSA-N 0.000 description 1
• NZWGCFLAGUIPBG-UHFFFAOYSA-N ethyl 2-(benzylcarbamoylamino)-1,3-oxazole-5-carboxylate Chemical compound C(C)OC(=O)C1=CN=C(O1)NC(=O)NCC1=CC=CC=C1 NZWGCFLAGUIPBG-UHFFFAOYSA-N 0.000 description 1
• NBABLVASYFPOEV-UHFFFAOYSA-N ethyl 2-amino-1,3-oxazole-4-carboxylate Chemical compound CCOC(=O)C1=COC(N)=N1 NBABLVASYFPOEV-UHFFFAOYSA-N 0.000 description 1
• UHUDJKCNXFBBHU-UHFFFAOYSA-N ethyl 2-amino-1,3-oxazole-5-carboxylate Chemical compound CCOC(=O)C1=CN=C(N)O1 UHUDJKCNXFBBHU-UHFFFAOYSA-N 0.000 description 1
• VNZXERIGKZNEKB-UHFFFAOYSA-N ethyl 2-amino-1,3-thiazole-5-carboxylate Chemical compound CCOC(=O)C1=CN=C(N)S1 VNZXERIGKZNEKB-UHFFFAOYSA-N 0.000 description 1
• DWXKSCKBUSAOKS-UHFFFAOYSA-N ethyl 2-chloro-3-oxopropanoate Chemical compound CCOC(=O)C(Cl)C=O DWXKSCKBUSAOKS-UHFFFAOYSA-N 0.000 description 1
• IZCSREAMZDZVFW-UHFFFAOYSA-N ethyl 5-amino-1,3-thiazole-2-carboxylate Chemical compound CCOC(=O)C1=NC=C(N)S1 IZCSREAMZDZVFW-UHFFFAOYSA-N 0.000 description 1
• LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 210000002950 fibroblast Anatomy 0.000 description 1
• 239000007941 film coated tablet Substances 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
• 238000011010 flushing procedure Methods 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 108010064365 glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine Proteins 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 239000003102 growth factor Substances 0.000 description 1
• 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 150000004820 halides Chemical group 0.000 description 1
• 125000001188 haloalkyl group Chemical group 0.000 description 1
• 150000008282 halocarbons Chemical class 0.000 description 1
• 230000023597 hemostasis Effects 0.000 description 1
• 239000002607 heparin antagonist Substances 0.000 description 1
• 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 125000004634 hexahydroazepinyl group Chemical group N1(CCCCCC1)* 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
• 150000004679 hydroxides Chemical class 0.000 description 1
• WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
• 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
• 230000000148 hypercalcaemia Effects 0.000 description 1
• 208000030915 hypercalcemia disease Diseases 0.000 description 1
• 239000005457 ice water Substances 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
• 229940096397 interleukin-8 Drugs 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 239000012948 isocyanate Substances 0.000 description 1
• 150000002513 isocyanates Chemical class 0.000 description 1
• 229940043355 kinase inhibitor Drugs 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 201000005296 lung carcinoma Diseases 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• SVWWNEYBEFASMP-UHFFFAOYSA-N methyl 2-aminopyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(N)=C1 SVWWNEYBEFASMP-UHFFFAOYSA-N 0.000 description 1
• QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
• FZXQUCUWEZQIHL-UHFFFAOYSA-N methyl 2h-triazole-4-carboxylate Chemical compound COC(=O)C=1C=NNN=1 FZXQUCUWEZQIHL-UHFFFAOYSA-N 0.000 description 1
• XQNRXJWIFJQYPP-UHFFFAOYSA-N methyl 4-(aminomethyl)thiophene-2-carboxylate Chemical compound COC(=O)C1=CC(CN)=CS1 XQNRXJWIFJQYPP-UHFFFAOYSA-N 0.000 description 1
• DXQCQLJXMICOKQ-UHFFFAOYSA-N methyl 4-amino-1-methylpyrrole-2-carboxylate Chemical compound COC(=O)C1=CC(N)=CN1C DXQCQLJXMICOKQ-UHFFFAOYSA-N 0.000 description 1
• YHOVYZINCVIRGK-UHFFFAOYSA-N methyl 4-aminopyridine-2-carboxylate Chemical compound COC(=O)C1=CC(N)=CC=N1 YHOVYZINCVIRGK-UHFFFAOYSA-N 0.000 description 1
• PYQRUDYLXHRTQU-UHFFFAOYSA-N methyl 4-aminopyrimidine-2-carboxylate Chemical compound COC(=O)C1=NC=CC(N)=N1 PYQRUDYLXHRTQU-UHFFFAOYSA-N 0.000 description 1
• KLKQGSISBRVCTK-UHFFFAOYSA-N methyl 5-aminofuran-2-carboxylate Chemical compound COC(=O)C1=CC=C(N)O1 KLKQGSISBRVCTK-UHFFFAOYSA-N 0.000 description 1
• LJYSUEZSIXOJFK-UHFFFAOYSA-N methyl 5-aminopyridine-2-carboxylate Chemical compound COC(=O)C1=CC=C(N)C=N1 LJYSUEZSIXOJFK-UHFFFAOYSA-N 0.000 description 1
• ROZWUNOYMSUTKS-UHFFFAOYSA-N methyl 5-nitrothiophene-2-carboxylate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)S1 ROZWUNOYMSUTKS-UHFFFAOYSA-N 0.000 description 1
• URSUGGQRGURMAM-UHFFFAOYSA-N methyl 6-aminopyrimidine-4-carboxylate Chemical compound COC(=O)C1=CC(N)=NC=N1 URSUGGQRGURMAM-UHFFFAOYSA-N 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
• 239000000236 nitric oxide synthase inhibitor Substances 0.000 description 1
• 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
• 229910000510 noble metal Inorganic materials 0.000 description 1
• 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 1
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 239000002674 ointment Substances 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 201000008968 osteosarcoma Diseases 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• 244000045947 parasite Species 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• GJVFBWCTGUSGDD-UHFFFAOYSA-L pentamethonium bromide Chemical class [Br-].[Br-].C[N+](C)(C)CCCCC[N+](C)(C)C GJVFBWCTGUSGDD-UHFFFAOYSA-L 0.000 description 1
• 239000003444 phase transfer catalyst Substances 0.000 description 1
• PARWUHTVGZSQPD-UHFFFAOYSA-N phenylsilane Chemical compound [SiH3]C1=CC=CC=C1 PARWUHTVGZSQPD-UHFFFAOYSA-N 0.000 description 1
• 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 125000004193 piperazinyl group Chemical group 0.000 description 1
• 125000003386 piperidinyl group Chemical group 0.000 description 1
• 229960004526 piracetam Drugs 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920005990 polystyrene resin Polymers 0.000 description 1
• RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 102000004196 processed proteins & peptides Human genes 0.000 description 1
• 239000000044 progesterone antagonist Substances 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 239000003881 protein kinase C inhibitor Substances 0.000 description 1
• 229940039716 prothrombin Drugs 0.000 description 1
• 239000000719 purinergic P2Y receptor antagonist Substances 0.000 description 1
• 125000004940 pyridazin-4-yl group Chemical group N1=NC=C(C=C1)* 0.000 description 1
• 125000004941 pyridazin-5-yl group Chemical group N1=NC=CC(=C1)* 0.000 description 1
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
• 238000010791 quenching Methods 0.000 description 1
• 230000000171 quenching effect Effects 0.000 description 1
• 230000035484 reaction time Effects 0.000 description 1
• 238000010992 reflux Methods 0.000 description 1
• 229940107685 reopro Drugs 0.000 description 1
• 230000010410 reperfusion Effects 0.000 description 1
• CSYSULGPHGCBQD-UHFFFAOYSA-N s-ethylisothiouronium diethylphosphate Chemical compound CCSC(N)=N.CCOP(O)(=O)OCC CSYSULGPHGCBQD-UHFFFAOYSA-N 0.000 description 1
• 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 210000002460 smooth muscle Anatomy 0.000 description 1
• 230000015590 smooth muscle cell migration Effects 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
• 239000007787 solid Substances 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 229960005202 streptokinase Drugs 0.000 description 1
• 150000003460 sulfonic acids Chemical class 0.000 description 1
• 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
• 239000011593 sulfur Chemical group 0.000 description 1
• YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 239000007885 tablet disintegrant Substances 0.000 description 1
• 125000001302 tertiary amino group Chemical group 0.000 description 1
• HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 1
• 150000003573 thiols Chemical class 0.000 description 1
• 229930192474 thiophene Natural products 0.000 description 1
• 150000003585 thioureas Chemical class 0.000 description 1
• RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 description 1
• 229940055764 triaz Drugs 0.000 description 1
• YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 150000003672 ureas Chemical class 0.000 description 1
• 210000003932 urinary bladder Anatomy 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1